机译:在3年期间Von Willebrand病中胃肠道出血的探索和治疗策略:VWD法国参考中心的回顾性国家调查
CHU Lille Hematol Transfus Lille France;
CHU Lille Hematol Transfus Lille France;
CHU Caen Lab Hematol Caen France;
CHU Caen Lab Hematol Caen France;
CHU Lyon Unite Hemostase Clin Ctr Reg Traitement Hemophilie Bron France;
Hop Necker Enfants Malad AP HP Paris France;
CHU Nantes Lab Hematol Nantes France;
CHU Bordeaux Pellegrin Bordeaux France;
CHU Clermont Ferrand Clermont Ferrand France;
CHU Brest Brest France;
CHU Dijon Dijon France;
CHU Toulouse Toulouse France;
CHU Caen Rouen France;
CH Metropole Savoie Site Chambery Chambery France;
CHU St Etienne St Etienne France;
CHU Strasbourg Strasbourg France;
CHU Montpellier Montpellier France;
Hop Lariboisiere GH St Louis Lariboisiere F Widal AP HP Lab Hematol Paris France;
CHU Lille Hematol Transfus Lille France;
CHU Lille Hematol Transfus Lille France;
机译:在3年期间Von Willebrand病中胃肠道出血的探索和治疗策略:VWD法国参考中心的回顾性国家调查
机译:出血史,von Willebrand因子和PFA-100(R)对1型von Willebrand疾病的诊断的影响:欧洲研究MCMDM-1VWD的结果。
机译:出血史,von Willebrand因子和PFA-100 ® sup>对1型von Willebrand疾病的诊断的影响:欧洲研究MCMDM-1VWD的结果
机译:重组von Willebrand因子治疗2A型von Willebrand病患者对其他治疗无反应的严重胃肠道出血:一例报告
机译:流血史,冯·威勒布兰德因子和PFA-100®对1型冯·威勒布兰病的诊断的影响:欧洲研究MCMDM-1VWD的结果